Hypertension | 11(50.0%) | 7 | 2 | 2 | 12(54.5%) | 6 | 3 | 3 | 0.910 | 0.763 |
Anorexia | 5(22.7%) | 4 | 1 | 0 | 8(36.4%) | 5 | 3 | 0 | 0.983 | 0.322 |
Fatigue | 16(72.7%) | 14 | 2 | 0 | 18(81.8%) | 16 | 2 | 0 | 0.518 | 0.472 |
Hand-foot-skin reaction | 5(22.7%) | 3 | 1 | 1 | 7(31.8%) | 4 | 3 | 0 | 0.458 | 0.498 |
Leucopenia | 3(13.6%) | 2 | 1 | 0 | 4(18.2%) | 3 | 1 | 0 | 0.170 | 0.680 |
Bleeding | 1(4.5%) | 0 | 1 | 0 | 0(0.0%) | 0 | 0 | 0 | 0.410 | 0.235 |
ALT abnormal | 6(27.3%) | 6 | 0 | 0 | 8(36.4%) | 7 | 1 | 0 | 0.419 | 0.517 |
Oral mucositis | 3(13.6%) | 1 | 2 | 0 | 5(22.7%) | 3 | 2 | 0 | 0.617 | 0.432 |
Hypothyroidism | 6(27.3%) | 4 | 2 | 0 | 6(27.3%) | 5 | 1 | 0 | 0.000 | 1.000 |
Diarrhea | 1(4.5%) | 0 | 0 | 1 | 2(9.1%) | 1 | 1 | 0 | 0.364 | 0.546 |
Gender n % | ||||
Male | 23(85.2) | 22(81.5) | 0.133 | 0.715 |
Female | 4(14.8) | 5(18.5) | ||
Age median | 54 | 56 | ||
ECOG PS n % | 0.912 | 0.340 | ||
1 | 8(29.6) | 5(18.5) | ||
2 | 19(70.4) | 22(81.5) | ||
Child-Pugh, n % | 0.078 | 0.780 | ||
A grade | 10(37.0) | 11(40.7) | ||
B grade ≤ 7 | 17(63.0) | 16(59.3) | ||
Stages (BCLC), n % | ||||
C | 27(100.0) | 27(100.0) | ||
AFP n % | 0.318 | 0.573 | ||
AFP ≥ 400 ng/mL | 16(59.3) | 18(66.7) | ||
AFP < 400 ng/mL | 11(40.7) | 9(33.3) | ||
HBV DNA n % | 1.421 | 0.233 | ||
≥ 1.0 × 103 IU/mL | 6(22.2) | 10(37.0) | ||
< 1.0 × 103 IU/mL | 21(77.8) | 17(63.0) | ||
PVTT n % | 0.092 | 0.761 | ||
PV1–3 | 18(66.7) | 16(59.3) | ||
PV4 | 2(7.4) | 3(11.1) | ||
EHS n % | 9(33.3) | 7(25.9) | 0.355 | 0.551 |